This issue we have a personal view on lipoatropy, a spotlight on a critical HIV/AIDS resource in our community and an answer to a question that seems to come up consistently on our TalkLine and in e-mails until next month.
Please note that this is not a complete list of all HIV-related treatment information. STEP strives to provide the very latest in HIV treatment information, research and drug development information. The most current research directions and antiretroviral drug data are provided throughout the Ezine publications. You will find highlight reports as well as extensive follow-up reports from many of the AIDS research and science conferences on the Ezine. In addition, all STEP quarterly treatment journals are available on our Web site at www.thebody.com/step/steppage.html
or by calling our Talkline at 1-877-597-STEP. STEP works hard to give unbiased treatment information to all interested parties. If you have comments, questions, suggestions or grievances, please contact firstname.lastname@example.org
Special thanks to the following for contributing written material or editing this publication:
- STEP Publications Advisory Committee:
Jeffrey Schouten, M.D., J.D. -- Chair
Jon Hubert, D.D.S.
Janice Price, R.N., M.Ed.
Brad Lichtenstein, N.D.
We also appreciate the financial support for this program from:
Disclaimer: STEP reviews a wide spectrum of HIV treatment options, but does not endorse any particular product, treatment, company, or individual. Participation in the preparation of the materials included in the STEP Ezine does not imply endorsement by any of the individuals who have contributed to the production.
STEP Ezine is a publication and trademark of the Seattle Treatment Education Project. Copyright © 2002.
Permission required to reprint articles or transcripts of articles (and gladly given in most instances).